These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 10682668)
1. Loss of DCC gene expression during ovarian tumorigenesis: relation to tumour differentiation and progression. Saegusa M; Machida D; Okayasu I Br J Cancer; 2000 Feb; 82(3):571-8. PubMed ID: 10682668 [TBL] [Abstract][Full Text] [Related]
2. CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression. Saegusa M; Machida D; Hashimura M; Okayasu I J Pathol; 1999 Nov; 189(3):326-37. PubMed ID: 10547593 [TBL] [Abstract][Full Text] [Related]
3. DCC expression is related to mucinous differentiation but not changes in expression of p21(WAF1/Cip1) and p27Kip1, apoptosis, cell proliferation and human papillomavirus infection in uterine cervical adenocarcinomas. Saegusa M; Okayasu I Br J Cancer; 1999 Apr; 80(1-2):51-8. PubMed ID: 10389977 [TBL] [Abstract][Full Text] [Related]
4. [Study on the expression of the gene deleted in colorectal carcinoma in ovarian carcinoma]. Li PL; Liu MM; Ni J Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):207-9. PubMed ID: 12885365 [TBL] [Abstract][Full Text] [Related]
5. Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Meinhold-Heerlein I; Bauerschlag D; Hilpert F; Dimitrov P; Sapinoso LM; Orlowska-Volk M; Bauknecht T; Park TW; Jonat W; Jacobsen A; Sehouli J; Luttges J; Krajewski M; Krajewski S; Reed JC; Arnold N; Hampton GM Oncogene; 2005 Feb; 24(6):1053-65. PubMed ID: 15558012 [TBL] [Abstract][Full Text] [Related]
6. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Gotley DC; Reeder JA; Fawcett J; Walsh MD; Bates P; Simmons DL; Antalis TM Oncogene; 1996 Aug; 13(4):787-95. PubMed ID: 8761300 [TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related]
8. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene. Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504 [TBL] [Abstract][Full Text] [Related]
9. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer. Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549 [TBL] [Abstract][Full Text] [Related]
10. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer. Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer. McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893 [TBL] [Abstract][Full Text] [Related]
12. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814 [TBL] [Abstract][Full Text] [Related]
14. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma. Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315 [TBL] [Abstract][Full Text] [Related]
15. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome. Brustmann H Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981 [TBL] [Abstract][Full Text] [Related]
16. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms. Wang P; Wu X; Chen W; Liu J; Wang X Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312 [TBL] [Abstract][Full Text] [Related]
17. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Bonome T; Lee JY; Park DC; Radonovich M; Pise-Masison C; Brady J; Gardner GJ; Hao K; Wong WH; Barrett JC; Lu KH; Sood AK; Gershenson DM; Mok SC; Birrer MJ Cancer Res; 2005 Nov; 65(22):10602-12. PubMed ID: 16288054 [TBL] [Abstract][Full Text] [Related]
18. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer]. Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380 [TBL] [Abstract][Full Text] [Related]
19. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC. Lassus H; Salovaara R; Aaltonen LA; Butzow R Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451 [TBL] [Abstract][Full Text] [Related]